179 related articles for article (PubMed ID: 33163374)
1. The role of transcription factor caudal-related homeobox transcription factor 2 in colorectal cancer.
Wu CC; Hsu TW; Yeh CC; Huang HB
Tzu Chi Med J; 2020; 32(4):305-311. PubMed ID: 33163374
[TBL] [Abstract][Full Text] [Related]
2. The clinical perspectives of CDX2 expression in colorectal cancer: a qualitative systematic review.
Olsen J; Espersen ML; Jess P; Kirkeby LT; Troelsen JT
Surg Oncol; 2014 Sep; 23(3):167-76. PubMed ID: 25126956
[TBL] [Abstract][Full Text] [Related]
3. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
Zhang BY; Jones JC; Briggler AM; Hubbard JM; Kipp BR; Sargent DJ; Dixon JG; Grothey A
Clin Colorectal Cancer; 2017 Jun; 16(2):124-128. PubMed ID: 27726953
[TBL] [Abstract][Full Text] [Related]
4. CDX2 downregulation is associated with poor differentiation and MMR deficiency in colon cancer.
Olsen J; Eiholm S; Kirkeby LT; Espersen ML; Jess P; Gögenür I; Olsen J; Troelsen JT
Exp Mol Pathol; 2016 Feb; 100(1):59-66. PubMed ID: 26551082
[TBL] [Abstract][Full Text] [Related]
5. The prognostic potential of CDX2 in colorectal cancer: Harmonizing biology and clinical practice.
Badia-Ramentol J; Gimeno-Valiente F; Duréndez E; Martínez-Ciarpaglini C; Linares J; Iglesias M; Cervantes A; Calon A; Tarazona N
Cancer Treat Rev; 2023 Dec; 121():102643. PubMed ID: 37871463
[TBL] [Abstract][Full Text] [Related]
6. Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancer.
Xu W; Zhu Y; Shen W; Ding W; Wu T; Guo Y; Chen X; Zhou M; Chen Y; Cui L; Du P
J Int Med Res; 2019 May; 47(5):1829-1842. PubMed ID: 30616445
[TBL] [Abstract][Full Text] [Related]
7. The homeobox gene CDX2 in colorectal carcinoma: a genetic analysis.
Sivagnanasundaram S; Islam I; Talbot I; Drummond F; Walters JR; Edwards YH
Br J Cancer; 2001 Jan; 84(2):218-25. PubMed ID: 11161380
[TBL] [Abstract][Full Text] [Related]
8. Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2.
Modica S; Morgano A; Salvatore L; Petruzzelli M; Vanier MT; Valanzano R; Esposito DL; Palasciano G; Duluc I; Freund JN; Mariani-Costantini R; Moschetta A
Gut; 2009 Sep; 58(9):1250-9. PubMed ID: 19221108
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-9-5p-CDX2 Axis: A Useful Prognostic Biomarker for Patients with Stage II/III Colorectal Cancer.
Nishiuchi A; Hisamori S; Sakaguchi M; Fukuyama K; Hoshino N; Itatani Y; Honma S; Maekawa H; Nishigori T; Tsunoda S; Obama K; Miyoshi H; Shimono Y; Taketo MM; Sakai Y
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31783700
[TBL] [Abstract][Full Text] [Related]
10. CDX2-positive Cancer of Unknown Primary With Upper-body Paralysis Was Dramatically Improved by Colorectal Cancer Chemotherapy.
Akagi H; Tanaka Y; Wada K; Takahashi M; Yoshida K; Domoto H
Anticancer Res; 2023 Jun; 43(6):2879-2884. PubMed ID: 37247890
[TBL] [Abstract][Full Text] [Related]
11. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of caudal-related homeobox transcription factor 2 inhibits the growth of transplanted colorectal tumors in nude mice.
Zheng JB; Qiao LN; Sun XJ; Qi J; Ren HL; Wei GB; Zhou PH; Yao JF; Zhang L; Jia PB
Mol Med Rep; 2015 Sep; 12(3):3409-3415. PubMed ID: 26005051
[TBL] [Abstract][Full Text] [Related]
13. Recombinant lentivirus with enhanced expression of caudal-related homeobox protein 2 inhibits human colorectal cancer cell proliferation in vitro.
He S; Sun XJ; Zheng JB; Qi J; Chen NZ; Wang W; Wei GB; Liu D; Yu JH; Lu SY; Wang H
Mol Med Rep; 2015 Aug; 12(2):1838-44. PubMed ID: 25847407
[TBL] [Abstract][Full Text] [Related]
14. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of CDX2 immunoexpression in poorly differentiated clusters of colorectal carcinoma.
Reggiani Bonetti L; Lionti S; Vitarelli E; Barresi V
Virchows Arch; 2017 Dec; 471(6):731-741. PubMed ID: 28819729
[TBL] [Abstract][Full Text] [Related]
16. CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia.
Hinoi T; Lucas PC; Kuick R; Hanash S; Cho KR; Fearon ER
Gastroenterology; 2002 Nov; 123(5):1565-77. PubMed ID: 12404231
[TBL] [Abstract][Full Text] [Related]
17. CDX2 Is a Prognostic Biomarker for Unresectable Metastatic Colorectal Cancer.
Mukohyama J; Agawa K; Yamashita K; Matsuda T; Shinoda M; Itano O; Kakeji Y
Anticancer Res; 2023 Aug; 43(8):3763-3767. PubMed ID: 37500172
[TBL] [Abstract][Full Text] [Related]
18. Methylation of promoter region of
Wang Y; Li Z; Li W; Liu S; Han B
Oncol Lett; 2016 Nov; 12(5):3229-3233. PubMed ID: 27899987
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Immunohistochemical Scoring System of CDX2 Expression as a Prognostic Biomarker in Colon Cancer.
Ilie-Petrov AC; Cristian DA; Grama FA; Chitul A; Blajin A; Popa A; Mandi DM; Welt L; Bara MA; Vrîncianu R; Ardeleanu CM
Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786321
[TBL] [Abstract][Full Text] [Related]
20. Identification of colorectal cancers with defective DNA damage repair by immunohistochemical profiling of mismatch repair proteins, CDX2 and BRCA1.
Rajarajan S; C E A; Jose B; Correa M; Sengupta S; Prabhu JS
Mol Clin Oncol; 2020 Nov; 13(5):57. PubMed ID: 32953111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
